Skip to main content

Table 1 Patients clinical characteristics

From: The prognosis prediction significance of Hounsfield unit value for stroke patients treated by intravenous thrombolysis

Ā 

Good prognosis group (nā€‰=ā€‰48)

Poor prognosis group (nā€‰=ā€‰36)

P

Age, meanā€‰Ā±ā€‰SD

70.6ā€‰Ā±ā€‰11.69

72.3ā€‰Ā±ā€‰8.46

0.458

Gender

Ā Ā 

0.051

Male

29 (60.4%)

22 (61.1%)

Ā 

Female

19 (39.6%)

14 (38.9%)

Ā 

Infarct side

Ā Ā 

0.705

Left

26 (54.2%)

18 (50%)

Ā 

Right

22 (45.8%)

18 (50%)

Ā 

Symptom onset to initial head CT, meanā€‰Ā±ā€‰SD

120.3ā€‰Ā±ā€‰70.12

141.4ā€‰Ā±ā€‰84.85

0.216

Initial NIHSS, median (range)

7 (2ā€“35)

14 (4ā€“35)

<ā€‰0.001

HBP

26(54.1%)

18(50%)

0.705

DM

15 (31.2%)

7 (19.4%)

0.223

AF

10 (20.8%)

11 (30.5%)

0.309

ASPECTS, median (range)

10 (8ā€“10)

9 (5ā€“10)

<ā€‰0.001

Hemorrhagic transformation

9 (18.8%)

16 (44.4%)

0.011

HMCAS

9 (18.8%)

14 (38.9%)

0.041

LNO

3 (6.2%)

8 (22.2%)

0.032

Infarct volume, median (range)

3.61(0.12ā€“82.10)

79.42(6.99ā€“285.26)

<ā€‰0.001

HU ratio, meanā€‰Ā±ā€‰SD

9.97ā€‰Ā±ā€‰0.19

9.75ā€‰Ā±ā€‰0.27

<ā€‰0.001

HU difference, meanā€‰Ā±ā€‰SD

11.14ā€‰Ā±ā€‰2.44

17.81ā€‰Ā±ā€‰7.61

<ā€‰0.001

  1. Bold values indicate the Pā€‰<ā€‰0.05
  2. AF atrial fibrillation, ASPECTS Alberta Stroke Program Early CT Score, DM diabetes mellitus, HBP high blood pressure, HMCAS hyperdense middle cerebral artery sign, HU Hounsfield unit, LNO lenticular nucleus obscuration, NIHSS National Institute of Health stroke scale